Orchestra BioMed Holdings had a revenue of 30.92M in the quarter ending Dec 31, 2025, with 3490.82%. This bring the company's revenue in the last twelve months to 33.48M, Decreased 1088.15%. In the fiscal year ending Dec 31, 2025, Orchestra BioMed Holdings had annual revenue of 33.48M with 1169.22% growth.